iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
48 hedge funds and large institutions have $43.7M invested in iShares Genomics Immunology and Healthcare ETF in 2020 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.52% less ownership
Funds ownership: 21.14% → 19.62% (-1.5%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
48
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.41M | |
| 2 | +$1.77M | |
| 3 | +$1.06M | |
| 4 |
WAP
Wealthcare Advisory Partners
West Chester,
Pennsylvania
|
+$961K |
| 5 |
LPL Financial
San Diego,
California
|
+$919K |
Top Sellers
| 1 | -$6.28M | |
| 2 | -$5.91M | |
| 3 | -$1.17M | |
| 4 |
SFS
Sowell Financial Services
North Little Rock,
Arkansas
|
-$616K |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$314K |